Gilenya - National Multiple Sclerosis Society

Skip to navigation Skip to content

Gilenya

Share

About this Medication
  • Brand Name: Gilenya (U.S.)
  • Chemical Name: fingolimod
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This is an oral medication in capsule form.


Description

Gilenya® is a new class of medication called a sphingosine 1-phosphate receptor modulator, which is thought to act by retaining certain white blood cells (lymphocytes) in the lymph nodes, thereby preventing those cells from crossing the blood-brain barrier into the central nervous system (CNS). Preventing the entry of these cells into the CNS reduces inflammatory damage to nerve cells.

Gilenya was approved by the U.S. Food and Drug Administration (FDA) in 2010 for adults with relapsing forms of MS to reduce the frequency of clinical relapses and to delay the accumulation of physical disability.

Click here to read the Gilenya Prescribing Information for healthcare professionals.

Click here to read the Gilenya Medication Guide for patients.

Support

Gilenya Go Program                                                                                                                                                                                          1-800-GILENYA (1-800-445-3692)
www.gilenya.com

 

Financial Assistance Program

Gilenya Go Program
1-800-445-3692
www.gilenya.com/c/ms-pill/go-program



Video

Gilenya®: What is it and How Does it Work?

This video features part one of a two-part interview with Aaron Miller, MD, who discusses Gilenya®. Dr. Miller explains how the medication works, clinical trials findings, and potential side effects. *This video was produced in November 2010.  In April of 2012 the FDA revised the prescribing information for Gilenya.  To learn more about Gilenya® and other disease modifying treatment options, download the Consensus on Disease-Modifying Therapies and summary.

Watch Now

Share